FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2108-2115 November 27, 2003 Number 22 Next

	Full Text PDF PDA Full Text Perspective by Scanu, A. M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in atherothrombogenesis, has been associated with an increased risk of vascular disease. We investigated this relation among older U.S. adults.

Methods In a prospective study of 5888 community-dwelling older adults (65 years of age or older) in the United States, 2375 women and 1597 men who were free of vascular disease provided base-line serum samples for analysis for levels of Lp(a) lipoprotein. These 3972 subjects were followed for a median of 7.4 years to evaluate the development of stroke and to track deaths from vascular causes and all causes. The men and women were divided into quintile groups according to the Lp(a) lipoprotein level at base line.

Results Using Cox proportional-hazards models, we determined the risk associated with each quintile level of Lp(a) lipoprotein, with the lowest quintile serving as the reference group. As compared with those in the lowest quintile, men in the highest quintile had three times the unadjusted risk of stroke (relative risk, 3.00; 95 percent confidence interval, 1.59 to 5.65), almost three times the risk of death associated with vascular events (relative risk, 2.54; 95 percent confidence interval, 1.59 to 4.08), and nearly twice the risk of death from all causes (relative risk, 1.76; 95 percent confidence interval, 1.31 to 2.36). Adjustment for age; sex; the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides; carotid-wall thickness; smoking status; the presence or absence of diabetes and systolic and diastolic hypertension; body-mass index; and other traditional risk factors had little effect on the final assessments. Similar analyses for women, which also included adjustment for estrogen use or nonuse, revealed no such relation.

Conclusions Among older adults in the United States, an elevated level of Lp(a) lipoprotein is an independent predictor of stroke, death from vascular disease, and death from any cause in men but not in women. These data support the use of Lp(a) lipoprotein levels in predicting the risk of these events in older men.

Source Information

From the Center for Cardiovascular Disease Prevention and Intervention, HeartMasters, Dallas, and the Division of Cardiology, Johns Hopkins Hospital, Baltimore (A.A.A.); the Department of Biostatistics, University of Washington, Seattle (C.T.); and the Department of Pathology, University of Vermont, Burlington (R.T.).

Address reprint requests to Dr. Ariyo at HeartMasters, 2411 Poinciana Place, Dallas, TX 75212 or at aa_ariyo{at}yahoo.com.

Full Text of this Article

Related Letters:

Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Saely C. H., Marte T., Drexel H., Kovesdy C. P., Ariyo A. A., Tracy R. P., Thach C.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:1150-1152, Mar 11, 2004. Correspondence

This article has been cited by other articles:

• Ix, J. H., Allison, M. A., Denenberg, J. O., Cushman, M., Criqui, M. H. (2008). Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans. The San Diego Population Study.. J Am Coll Cardiol 51: 2347-2354 [Abstract] [Full Text]  
• Bennet, A., Di Angelantonio, E., Erqou, S., Eiriksdottir, G., Sigurdsson, G., Woodward, M., Rumley, A., Lowe, G. D. O., Danesh, J., Gudnason, V. (2008). Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data. Arch Intern Med 168: 598-608 [Abstract] [Full Text]  
• Chien, K.-L., Hsu, H.-C., Su, T.-C., Sung, F.-C., Chen, M.-F., Lee, Y.-T. (2008). Lipoprotein(a) and Cardiovascular Disease in Ethnic Chinese: The Chin-Shan Community Cardiovascular Cohort Study. Clin. Chem. 54: 285-291 [Abstract] [Full Text]  
• Kamstrup, P. R., Benn, M., Tybjaerg-Hansen, A., Nordestgaard, B. G. (2008). Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study. Circulation 117: 176-184 [Abstract] [Full Text]  
• Kiechl, S., Willeit, J., Mayr, M., Viehweider, B., Oberhollenzer, M., Kronenberg, F., Wiedermann, C. J., Oberthaler, S., Xu, Q., Witztum, J. L., Tsimikas, S. (2007). Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study. Arterioscler. Thromb. Vasc. Bio. 27: 1788-1795 [Abstract] [Full Text]  
• Smolders, B., Lemmens, R., Thijs, V. (2007). Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies. Stroke 38: 1959-1966 [Abstract] [Full Text]  
• CICEK, H., BAYIL, S., ZER, Y., CELIK, A., GEYIKLI, I. (2007). Comparison of Lipoprotein(a) Levels between Elderly and Middle-Aged Men with Coronary Artery Disease. Ann. N. Y. Acad. Sci. 1100: 179-184 [Abstract] [Full Text]  
• Wiberg, B., Sundstrom, J., Arnlov, J., Terent, A., Vessby, B., Zethelius, B., Lind, L. (2006). Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up. Stroke 37: 2898-2903 [Abstract] [Full Text]  
• Suk Danik, J., Rifai, N., Buring, J. E., Ridker, P. M (2006). Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.. JAMA 296: 1363-1370 [Abstract] [Full Text]  
• Rice, T. W., Lumsden, A. B. (2006). Optimal Medical Management of Peripheral Arterial Disease. VASC ENDOVASCULAR SURG 40: 312-327 [Abstract]  
• Hartmann, M., von Birgelen, C., Mintz, G. S., Stoel, M. G., Eggebrecht, H., Wieneke, H., Fahy, M., Neumann, T., van der Palen, J., Louwerenburg, H. W., Verhorst, P. M.J., Erbel, R. (2006). Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries. J Am Coll Cardiol 48: 446-452 [Abstract] [Full Text]  
• Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e873-e923 [Abstract] [Full Text]  
• Ohira, T., Schreiner, P. J., Morrisett, J. D., Chambless, L. E., Rosamond, W. D., Folsom, A. R. (2006). Lipoprotein(a) and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 37: 1407-1412 [Abstract] [Full Text]  
• Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 1583-1633 [Abstract] [Full Text]  
• Tsimikas, S., Willerson, J. T., Ridker, P. M. (2006). C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.. J Am Coll Cardiol 47: C19-C31 [Abstract] [Full Text]  
• Ingelsson, E., Arnlov, J., Sundstrom, J., Zethelius, B., Vessby, B., Lind, L. (2005). Novel Metabolic Risk Factors for Heart Failure. J Am Coll Cardiol 46: 2054-2060 [Abstract] [Full Text]  
• Lynch, J. K., Han, C. J., Nee, L. E., Nelson, K. B. (2005). Prothrombotic Factors in Children With Stroke or Porencephaly. Pediatrics 116: 447-453 [Abstract] [Full Text]  
• Song, K.-H., Ko, S. H., Kim, H.-W., Ahn, Y.-B., Lee, J.-M., Son, H.-S., Yoon, K.-H., Cha, B.-Y., Lee, K.-W., Son, H.-Y. (2005). Prospective Study of Lipoprotein(a) as a Risk Factor for Deteriorating Renal Function in Type 2 Diabetic Patients With Overt Proteinuria. Diabetes Care 28: 1718-1723 [Abstract] [Full Text]  
• Zambrelli, E., Emanuele, E., Marcheselli, S., Montagna, L., Geroldi, D., Micieli, G. (2005). Apo(a) size in ischemic stroke: Relation with subtype and severity on hospital admission. Neurology 64: 1366-1370 [Abstract] [Full Text]  
• Shlipak, M. G., Fried, L. F., Cushman, M., Manolio, T. A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., Psaty, B. (2005). Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors. JAMA 293: 1737-1745 [Abstract] [Full Text]  
• Berglund, L., Ramakrishnan, R. (2004). Lipoprotein(a): An Elusive Cardiovascular Risk Factor. Arterioscler. Thromb. Vasc. Bio. 24: 2219-2226 [Abstract] [Full Text]  
• Rifai, N., Ma, J., Sacks, F. M., Ridker, P. M., Hernandez, W. J. L., Stampfer, M. J., Marcovina, S. M. (2004). Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study. Clin. Chem. 50: 1364-1371 [Abstract] [Full Text]  
• Arenillas, J. F., Molina, C. A., Chacon, P., Rovira, A., Montaner, J., Coscojuela, P., Sanchez, E., Quintana, M., Alvarez-Sabin, J. (2004). High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 63: 27-32 [Abstract] [Full Text]  
• Ridker, P. M, Brown, N. J., Vaughan, D. E., Harrison, D. G., Mehta, J. L. (2004). Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events. Circulation 109: IV-6-IV-19 [Full Text]  
• Saely, C. H., Marte, T., Drexel, H., Kovesdy, C. P., Ariyo, A. A., Tracy, R. P., Thach, C. (2004). Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly. NEJM 350: 1150-1152 [Full Text]  
• (2004). Do Lp(a) Levels Have Prognostic Value in Elders?. Journal Watch Cardiology 2004: 4-4 [Full Text]  
• (2003). Lp(a) Level Predicts Vascular Events in Older Men. JWatch General 2003: 2-2 [Full Text]